Anti Neutrophil Cytoplasmic Antibody (Indirect IF)
The ANCA (Indirect IF) Test detects anti-neutrophil cytoplasmic antibodies in blood, helping diagnose autoimmune disorders such as Vasculitis.
This test is recommended to:
- Diagnose autoimmune vasculitis
- Detect ANCA-associated disorders
- Differentiate types of vasculitis
- Monitor disease activity and treatment response
- Support diagnosis of systemic autoimmune diseases
ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY (INDIRECT IF) Test Purpose
The Anti-Neutrophil Cytoplasmic Antibody (ANCA) Test by Indirect Immunofluorescence (Indirect IF) detects ANCAs, which are autoantibodies directed against proteins found in the cytoplasm of neutrophils, a type of white blood cell. These antibodies are commonly associated with ANCA-associated vasculitis, a group of autoimmune diseases that cause inflammation and damage to small and medium-sized blood vessels.
The Indirect IF method helps identify the characteristic cytoplasmic (C-ANCA) and perinuclear (P-ANCA) staining patterns, which provide valuable information for diagnosing autoimmune conditions such as Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), and Eosinophilic Granulomatosis with Polyangiitis (EGPA). In some cases, P-ANCA may also be seen in inflammatory bowel disease, autoimmune liver disease, and other autoimmune conditions.
Healthcare providers commonly recommend this test for individuals experiencing symptoms such as persistent fever, unexplained weight loss, chronic sinus infections, coughing up blood, shortness of breath, kidney problems, skin rashes, joint pain, or nerve-related symptoms suggestive of systemic vasculitis.
Furthermore, the ANCA (Indirect IF) Test is often performed alongside ANCA PR3 (Proteinase 3), ANCA MPO (Myeloperoxidase), inflammatory markers, kidney function tests, and other autoimmune investigations to improve diagnostic accuracy and monitor disease activity.
ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY (INDIRECT IF) Test is Recommended for Individuals:
- Individuals suspected of having ANCA-associated vasculitis.
- Patients with persistent inflammation affecting the kidneys, lungs, skin, or nervous system.
- People experiencing unexplained blood in the urine, kidney dysfunction, or reduced kidney function.
- Individuals with chronic sinusitis, nasal ulcers, coughing up blood, or unexplained respiratory symptoms.
- Patients with unexplained skin rashes, joint pain, muscle pain, or nerve damage.
- Individuals with suspected autoimmune disorders involving blood vessel inflammation.
- Patients requiring monitoring of diagnosed ANCA-associated vasculitis.
- Individuals advised by their healthcare provider to undergo autoimmune antibody testing.
FAQs
1. What is the ANCA (Indirect IF) Test used for?
The ANCA (Indirect IF) Test detects autoantibodies associated with autoimmune vasculitis. It helps diagnose conditions such as Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), and Eosinophilic Granulomatosis with Polyangiitis (EGPA), while also supporting disease monitoring.
2. Do I need to fast before the ANCA (Indirect IF) Test?
No. Fasting is generally not required for this blood test. However, always follow any specific instructions provided by your healthcare provider before sample collection.
3. What does a positive ANCA result mean?
A positive ANCA result may indicate an autoimmune disorder involving inflammation of blood vessels, particularly ANCA-associated vasculitis. However, the test alone cannot confirm a diagnosis. Your doctor will interpret the result together with your symptoms, imaging findings, biopsy results, and other laboratory tests, such as PR3-ANCA and MPO-ANCA, to establish an accurate diagnosis and determine the most appropriate treatment plan.